Granules India Board on Tuesday approved the drugmaker’s proposals to raise ₹1,762.50 crore through issue of preferential convertible warrants and equity shares.
The company plans to issue 2.5 crore convertible warrants for ₹585 each aggregating up to ₹1,462.50 crore on preferential basis to members of the promoter group and non-promoter investor category.
Granules also plans to raise funds through issue of a more than 51.28 lakh equity shares (face value of ₹1 each) for ₹585 per share, aggregating up to ₹300 crore on preferential basis to various non-promoter investor category.
The warrants will be convertible into equivalent number of equity shares (face value of ₹1 each), in one or more tranches within 18 months from the date of allotment. The company will be convening an EGM on January 22 for seeking necessary approval.
Published – December 23, 2025 11:38 pm IST
